- Home
- DNTH vs PRA Comparison
DNTH vs PRA Comparison
Compare DNTH & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- PRA
- Stock Information
- Founded
- DNTH 2015
- PRA 1976
- Country
- DNTH United States
- PRA United States
- Employees
- DNTH N/A
- PRA N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- PRA Property-Casualty Insurers
- Sector
- DNTH Health Care
- PRA Finance
- Exchange
- DNTH Nasdaq
- PRA Nasdaq
- Market Cap
- DNTH 670.7M
- PRA N/A
- IPO Year
- DNTH N/A
- PRA N/A
- Fundamental
- Price
- DNTH $22.29
- PRA $14.79
- Analyst Decision
- DNTH Strong Buy
- PRA Buy
- Analyst Count
- DNTH 9
- PRA 3
- Target Price
- DNTH $46.43
- PRA $17.67
- AVG Volume (30 Days)
- DNTH 245.5K
- PRA 176.8K
- Earning Date
- DNTH 03-20-2025
- PRA 02-25-2025
- Dividend Yield
- DNTH N/A
- PRA N/A
- EPS Growth
- DNTH N/A
- PRA N/A
- EPS
- DNTH N/A
- PRA 0.84
- Revenue
- DNTH $5,366,000.00
- PRA $1,162,157,000.00
- Revenue This Year
- DNTH $100.14
- PRA N/A
- Revenue Next Year
- DNTH N/A
- PRA $0.56
- P/E Ratio
- DNTH N/A
- PRA $17.60
- Revenue Growth
- DNTH 51.41
- PRA 2.62
- 52 Week Low
- DNTH $18.35
- PRA $10.76
- 52 Week High
- DNTH $33.77
- PRA $17.79
- Technical
- Relative Strength Index (RSI)
- DNTH 49.77
- PRA 41.23
- Support Level
- DNTH $21.28
- PRA $14.50
- Resistance Level
- DNTH $23.28
- PRA $15.37
- Average True Range (ATR)
- DNTH 1.75
- PRA 0.38
- MACD
- DNTH 0.17
- PRA 0.02
- Stochastic Oscillator
- DNTH 79.92
- PRA 27.41
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.